1Douglas WW,Tazelaar HI), Hartmml TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med,2001,164(7) : 1182-1185.
2Grau JM, Miro O, Pedrol E, et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol, 1996,23( 11 ) : 1921-1926.
3Takizawa H, Suzuki N, Yanagawa T,et al. Pulmonary involvement of collagen vascular disease:studies on prognostic factors from basic and clinical viewpoints. Nihon Kyobu Shikkan Gakkai Zasshi,1995,33 (Suppl) :291-295.
4ho M, Kaim S,Suzuki S, et al.Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol, 1999,18(6) :462-467.
5Takada T, Suzuki E, Nakano M, et al. Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease. Intern Med, 1998,37(8) :669-673.
6Friedman AW, Targoff IN, Amett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum, 1996, 26( 1 ) : 459-467.
7Toyoshima M, Sato A, Chida K, et al. Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis. Nihon Kyobu Shikkan Gakkai Zasshi, 1997,35(3) :281-287.
8Ihn H, Asano Y, Kubo M, et al.Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology(Oxford) ,2002,41 ( 11 ) : 1268-1272.
9Bandoh S, Fujita J, Ohtsuki Y, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis, 2000,59 (4) : 257-262.
10Nakajirna H, l-Iarigai M,Hara M, et al. KI-6 as a novel .serum marker for interstitial peumonia associated with collagen diseases.J Rheumatol, 2000,27 (5) : 1164-1170.
